Intelligent prescription system combined with a national pharmacloud for geriatrics care

Mei Hua Wang, Tzu Hsuan Lu, Wei Ni Huang, Yu Ting Yeh

Research output: Contribution to journalArticle

Abstract

Introduction: The elderly are high risk for chronic diseases and multiple drug use–two problems that make geriatric medication use more complex; as a result, the possibility of duplicate prescriptions and drug interactions increase, affecting patient safety. The objective of this study was to develop an Intelligent Prescription System Combined with a National PharmaCloud for Geriatrics Care (IPSPcG) that can reduce the occurrence of duplicate prescriptions. Methods: The system was implemented in a teaching hospital in Taiwan. The IPSPcG consists of two major components: (1) the collection module and (2) Intelligent Knowledge-base Module. Data on medication prescription behaviors and medication-blocking rates were gathered from January 2015 to December 2017. Results: Overall, during the study period, the IPSPcG system included 39,678 prescriptions. Antihypertensive medications were included at the highest proportion (8962, 22.6%). The system changed physician’s prescription behavior (p < .001) and decreased potential duplicate prescription times (14%). Conclusion: The results of this study show that integrating appropriate recommendations from drug messages can reduce repeated drug prescriptions. Due to the diversity of diseases, the diversity and accuracy of medical advice must improve. The results of the ‘Comprehensive Prescription Information’ provided by this system can serve as a reference for future research.

Original languageEnglish
Pages (from-to)559-564
Number of pages6
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume18
Issue number5
DOIs
Publication statusPublished - Sep 3 2018

Fingerprint

Geriatrics
Prescriptions
Drug Prescriptions
Knowledge Bases
Prescription Drugs
Patient Safety
Taiwan
Drug Interactions
Information Systems
Teaching Hospitals
Pharmaceutical Preparations
Antihypertensive Agents
Physicians

Keywords

  • geriatrics care
  • Intelligent
  • pharmacloud
  • prescription
  • prescription duplicate

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this

Intelligent prescription system combined with a national pharmacloud for geriatrics care. / Wang, Mei Hua; Lu, Tzu Hsuan; Huang, Wei Ni; Yeh, Yu Ting.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 18, No. 5, 03.09.2018, p. 559-564.

Research output: Contribution to journalArticle

@article{b31bd80ab6e649fbad8aea2f3a32dd27,
title = "Intelligent prescription system combined with a national pharmacloud for geriatrics care",
abstract = "Introduction: The elderly are high risk for chronic diseases and multiple drug use–two problems that make geriatric medication use more complex; as a result, the possibility of duplicate prescriptions and drug interactions increase, affecting patient safety. The objective of this study was to develop an Intelligent Prescription System Combined with a National PharmaCloud for Geriatrics Care (IPSPcG) that can reduce the occurrence of duplicate prescriptions. Methods: The system was implemented in a teaching hospital in Taiwan. The IPSPcG consists of two major components: (1) the collection module and (2) Intelligent Knowledge-base Module. Data on medication prescription behaviors and medication-blocking rates were gathered from January 2015 to December 2017. Results: Overall, during the study period, the IPSPcG system included 39,678 prescriptions. Antihypertensive medications were included at the highest proportion (8962, 22.6{\%}). The system changed physician’s prescription behavior (p < .001) and decreased potential duplicate prescription times (14{\%}). Conclusion: The results of this study show that integrating appropriate recommendations from drug messages can reduce repeated drug prescriptions. Due to the diversity of diseases, the diversity and accuracy of medical advice must improve. The results of the ‘Comprehensive Prescription Information’ provided by this system can serve as a reference for future research.",
keywords = "geriatrics care, Intelligent, pharmacloud, prescription, prescription duplicate",
author = "Wang, {Mei Hua} and Lu, {Tzu Hsuan} and Huang, {Wei Ni} and Yeh, {Yu Ting}",
year = "2018",
month = "9",
day = "3",
doi = "10.1080/14737167.2018.1492912",
language = "English",
volume = "18",
pages = "559--564",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Intelligent prescription system combined with a national pharmacloud for geriatrics care

AU - Wang, Mei Hua

AU - Lu, Tzu Hsuan

AU - Huang, Wei Ni

AU - Yeh, Yu Ting

PY - 2018/9/3

Y1 - 2018/9/3

N2 - Introduction: The elderly are high risk for chronic diseases and multiple drug use–two problems that make geriatric medication use more complex; as a result, the possibility of duplicate prescriptions and drug interactions increase, affecting patient safety. The objective of this study was to develop an Intelligent Prescription System Combined with a National PharmaCloud for Geriatrics Care (IPSPcG) that can reduce the occurrence of duplicate prescriptions. Methods: The system was implemented in a teaching hospital in Taiwan. The IPSPcG consists of two major components: (1) the collection module and (2) Intelligent Knowledge-base Module. Data on medication prescription behaviors and medication-blocking rates were gathered from January 2015 to December 2017. Results: Overall, during the study period, the IPSPcG system included 39,678 prescriptions. Antihypertensive medications were included at the highest proportion (8962, 22.6%). The system changed physician’s prescription behavior (p < .001) and decreased potential duplicate prescription times (14%). Conclusion: The results of this study show that integrating appropriate recommendations from drug messages can reduce repeated drug prescriptions. Due to the diversity of diseases, the diversity and accuracy of medical advice must improve. The results of the ‘Comprehensive Prescription Information’ provided by this system can serve as a reference for future research.

AB - Introduction: The elderly are high risk for chronic diseases and multiple drug use–two problems that make geriatric medication use more complex; as a result, the possibility of duplicate prescriptions and drug interactions increase, affecting patient safety. The objective of this study was to develop an Intelligent Prescription System Combined with a National PharmaCloud for Geriatrics Care (IPSPcG) that can reduce the occurrence of duplicate prescriptions. Methods: The system was implemented in a teaching hospital in Taiwan. The IPSPcG consists of two major components: (1) the collection module and (2) Intelligent Knowledge-base Module. Data on medication prescription behaviors and medication-blocking rates were gathered from January 2015 to December 2017. Results: Overall, during the study period, the IPSPcG system included 39,678 prescriptions. Antihypertensive medications were included at the highest proportion (8962, 22.6%). The system changed physician’s prescription behavior (p < .001) and decreased potential duplicate prescription times (14%). Conclusion: The results of this study show that integrating appropriate recommendations from drug messages can reduce repeated drug prescriptions. Due to the diversity of diseases, the diversity and accuracy of medical advice must improve. The results of the ‘Comprehensive Prescription Information’ provided by this system can serve as a reference for future research.

KW - geriatrics care

KW - Intelligent

KW - pharmacloud

KW - prescription

KW - prescription duplicate

UR - http://www.scopus.com/inward/record.url?scp=85049633286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049633286&partnerID=8YFLogxK

U2 - 10.1080/14737167.2018.1492912

DO - 10.1080/14737167.2018.1492912

M3 - Article

VL - 18

SP - 559

EP - 564

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 5

ER -